The fall of Lusix: Inside the collapse of Israel's synthetic diamond pioneer

The fall of Lusix: Inside the collapse of Israel's synthetic diamond pioneer. The company has submitted a request for a stay of proceedings to the court due to debts of about $28 million. According to the company, it needs six weeks to complete a merger with another company, after which shareholders will inject $22 million. Lusix has raised over $150 million to date.

Proptech startup Localize shuts down US operations amid real estate crisis. The volume of real estate transactions in the US has decreased significantly in the last two years, leading to a reduction in the company's activities that provide data tools for apartment buyers and agents. However, sister company Madlan's activities in Israel will continue as usual.

DreaMed secures $3M and strategic deals amid CEO's reserve IDF duty. The AI solution developed by DreaMed is designed to provide treatment recommendations to millions of people with diabetes who do not have access to endocrinologists. ?

XRHealth is taking physical patient care into the digital world. The Israeli company has introduced virtual reality to healthcare professionals and patients looking to change the way therapies are delivered and measured.

Zim surges on strong Q2 performance and upgraded forecasts. A booming container market prompts Zim to sharply upgrade its annual profit outlook.